Outcomes4Me Acquires Geno.Me and Realyze Intelligence to Expand AI Cancer Care Platform

May 21, 2026
Outcomes4Me has acquired Geno.Me and Realyze Intelligence to strengthen its AI platform for cancer care and clinical trial matching. The company also appointed UPMC Hillman Cancer Center CIO Scot Stevens as Strategic Advisor.

Outcomes4Me announced in a press release that it has completed the acquisitions of Geno.Me and Realyze Intelligence. The move aims to strengthen Outcomes4Me's AI platform for patient engagement, personalized treatment, and clinical trial access.

Geno.Me, based in Milwaukee, connects patient data with researchers through integrations with major electronic health record systems such as Epic, Cerner, and Meditech. Patients can access and share their health data securely for research or clinical use. Realyze Intelligence, developed with input from several National Cancer Institute accredited centers, uses AI to convert medical records into structured oncology data models for rapid clinical trial matching.

Outcomes4Me also appointed Scot Stevens, Chief Information Officer at UPMC Hillman Cancer Center, as Strategic Advisor. Stevens previously worked with Realyze Intelligence in its early stages and will assist in integrating the technology into Outcomes4Me's patient platform.

The combined technologies are expected to enhance Outcomes4Me's capabilities in clinical trial recruitment and real world evidence generation, supporting more than 400,000 cancer patients with personalized treatment insights and access to new research opportunities.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Funding News AI Brief AI Brief (X)

More from: Life Sciences

05/21
Canvas Medical Introduces Studio for Custom EMR Workflow Creation
05/21
MGI Tech Presents New Laboratory Automation and Multi Omics Systems at SLAS 2026
05/21
RADIN Health and AZmed Expand AI Radiology Integration with FDA Clearance for AZtrauma
05/21
Vu Technologies and Moffitt Cancer Center Use NVIDIA DGX Spark for 3D Tumor Visualization
05/21
Hyro and Five9 Partner to Bring AI Agents to Healthcare Contact Centers

More from: Funding

05/21
Axion Semiconductor Acquires Moov Technologies to Expand Supply Chain Platform
05/21
Arkeus Raises $18 Million to Expand AI Sensing Systems for Defense
05/21
NanoCo Raises $12 Million Seed Round After Declining $20 Million Buyout
05/21
OpenAI Prepares Confidential IPO Filing with Goldman Sachs and Morgan Stanley
05/21
Mistral AI Acquires Emmi AI to Expand Industrial Engineering Capabilities

Subscribe to AI Funding Brief

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You May Also Like